PP-405
$49.98
PP-405, a small-molecule research compound, inhibits the mitochondrial pyruvate carrier complex, specifically MPC1 and MPC2. Explore its potential in altering cellular metabolism as research continues.
Overview
PP-405, often referred to as PP405, is an innovative small-molecule research compound currently under development by Pelage Pharmaceuticals. This compound primarily functions as an inhibitor of the mitochondrial pyruvate carrier (MPC) complex, targeting both MPC1 and MPC2. Recent literature highlights its potential role in modifying intracellular metabolic pathways, making it a subject of interest in ongoing research endeavors. Currently, PP-405 is undergoing preclinical and early clinical studies, exploring its mechanistic impact on cellular metabolism, particularly in various research applications.
Key Features
- Research compound targeting mitochondrial pyruvate carrier
- Inhibits MPC1 and MPC2 specifically
- Emerging literature on its role in metabolic pathways
- Undergoing preclinical and early clinical studies
- Potential applications in diverse research fields
Specifications
| Property | Details |
|---|---|
| Category | Liquids |
| Research Phase | Preclinical/Early Clinical |
FAQ
What is PP-405 used for?
PP-405 is primarily used in research settings to study its effects on mitochondrial function and cellular metabolism.
How is PP-405 administered?
PP-405 is available in liquid form, making it easy to incorporate into various research protocols.
Is PP-405 safe for human consumption?
PP-405 is a research compound and should only be used in laboratory settings under appropriate supervision and compliance with regulations.
Explore the potential of PP-405 in your research today.
Related Products
Browse more in Liquids.
Always read the label and use products as directed. Consult a qualified professional where appropriate.
| Form | Liquid |
|---|---|
| Strength | 50mcg per ml/30ml/1.5mg, 100mcg per ml/30ml/3mg |
Related products
Caps & Tabs
